[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610954":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":10,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":10,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Laboratoires Thea","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Group receiving Blephaderm",null,[12],"Other: Cosmetic: Blephaderm",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"OTHER","Cosmetic: Blephaderm","Preservative free eyelid cream: Aqua (water), oleyl erucate, trehalose, sodium acrylates copolymer, lecithin, Ophiopogon japonicus root extract, hydrolyzed hyaluronic acid, maltodextrin, tocopherol, sodium hydroxide, phytic acid, Glycine soja (soybean) oil, Helianthus annuus seed oil.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Medical Affairs Director","CONTACT","+33 4 73 98 14 36","florence.noirt@theapharma.com",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Pierre-Vincent Jacomet Private Practice","RECRUITING","Paris","France","FR",{"type":33,"coordinates":34},"Point",[35,36],2.3488,48.85341,{"lat":36,"lon":35},[39],{"name":40,"role":22,"phone":10,"phoneExt":10,"email":10},"Pierre-Vincent Jacomet, Dr.",{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100610954","evaluation-of-patient-satisfaction-with-blephaderm-as-a-complementary-care-in-post-eyelid-surgery-100610954",false,"NCT07234292","Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery","Evaluation of Patient Satisfaction With a New Preservative-free Eyelid Cream as a Complementary Care in Post-eyelid Surgery: The ADMIRE Study","Inclusion Criteria:\n\n* Age ≥ 18 years old\n* Patients planning a blepharoplasty or a ptosis surgery in at least one eye.\n* Patient affiliated to a health social security system\n* Female of childbearing potential should use a medically accepted contraceptive regimen since at least 12 weeks before the beginning of the study, during all the study and at least 1 month after the study end.\n\nExclusion Criteria:\n\nIn terms of population:\n\n* Pregnant or nursing woman or planning a pregnancy during the study.\n* Patient who had been deprived of their freedom by administrative or legal decision\n* Minor patient.\n* Major patient who is under guardianship or who is not able to express his non opposition.\n* Patient suspected to be non-compliant according to the investigator's judgment.\n* Patient enrolled in another clinical trial or which exclusion period is not over.\n\nIn terms of associated pathology\n\n* Patient with a history or active systemic condition or receiving a medication which, in the investigator's judgment, put the patient at undue risk.\n* Patient suffering from a severe or progressive disease.\n* Patient with known or suspected hypersensitivity to one of the components of the product.\n\nRelated to previous or ongoing treatment\n\n* Patient undergoing a topical treatment on the test area or a systemic treatment.\n* Patient under a long-term corticosteroid, NSAID or HIV therapy at the investigator appreciation.\n* Patient under immunosuppressive therapy\n* Patient under bisphosphonate therapy\n* Patient having Type 1 diabetes\n* Patient having atopic or eczema skin\n\nIn terms of lifestyle\n\n* Intensive exposure to sunlight or UV-rays foreseen during the study.\n* Patient planning to change her\u002Fhis life habits during the study.\n* Patient with an excessive consumption of alcohol and\u002For tobacco defined as:\n* an excessive consumption of alcohol: Drinking more than\n* 4 units a day for adult men and more than 2 units a day for adult women,\n* an excessive consumption of tobacco: ≥15-20 Cigarettes Per Day (CPD).","ALL","18 Years",{"count":53,"type":54},30,"ESTIMATED","OBSERVATIONAL","The goal of this non-interventional, open and monocentric study is to evaluate the satisfaction of 30 patients, after 3 months with Blephaderm eyelid cream, as a complementary care in post-eyelid surgery (Blepharopasty or ptosis).\n\nThe participant will be asked to use Blephaderm twice a day. The patient satisfaction will be evaluated using a VAS scale.",[58],"Eyelid; Wound","2026-04-28",{"date":61,"type":62},"2026-05-04","ACTUAL",{"date":64,"type":62},"2025-10-30",{"date":66,"type":54},"2026-12-15",{"name":5,"class":6},1]